Expert Interview
A Third Look at the potential of semaglutide as adjunct treatment for patients with T2D and CKD and the results from the kidney outcomes FLOW trial.
Ticker(s): NVOInstitution: Renal Care Consultant
- Clinical nephrologist covering inpatient and outpatient consultation for acute and chronic renal failure, hypertension, and ESRD at Beaumont Health Systems.
- Delivers Chronic kidney disease education and provides hemodialysis and peritoneal dialysis services
- Treats 6 patients with IgA Nephropathy and is familiar with the PROTECT study data of Sparsentan
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
